CRO

Huntingdon, Harlan planning to rebrand; SynteractHCR focuses on oncology;

> After acquiring CRO Harlan Laboratories last year, Huntingdon Life Sciences is preparing to rebrand the combined company, which will split its operations between contract research and research models. News

> SynteractHCR has created the new position of vice president of strategic development, appointing CRO veteran Etienne Drouet to the post in an effort to boost its capacity in oncology and complex trials. Story